16th Congress of the European Hematology Association

Search’n Build™

Use this index to quickly access speakers by name. A  B  C  D  E  F  G  H  I  J  K  L  M  N  O   P  Q   R  S  T  U   V  W  X   Y   Z  

Scroll down to see presentations grouped by speakers.
A
Jane Apperley  

Chair comments
2011-06-10 - English


B
Andrea Bacigalupo  

Unrelated donors
2011-06-10 - English

Trevor Baglin  

Recurrent venous thrombosis
2011-06-10 - English

Andre Baruchel  

CNS leukemia in ALL: how to prevent and how to treat
2011-06-10 - English

Renato Bassan  

Chair comments
2011-06-10 - English

Erik Berntorp  

New treatments in hemophilia
2011-06-10 - English

J.M. Bjorkholm  

Chair comments
2011-06-10 - English

Michael Boeckh  

Treatment of viral infections
2011-06-10 - English

Jan A. Burger  

Mechanisms of homing and tissue invasion in CLL
2011-06-10 - English

J. Bussel  

The role of thrombopoietic agents
2011-06-10 - English
to be announced!


C
Clara Camaschella  

Chair comments
2011-06-10 - English

Marina Cavazzana-Calvo  

Gene therapy and thallasemia
2011-06-12 - English

Stefan Constantinescu  

Molecular pathogenesis
2011-06-10 - English


D
R. Dalla Favera  

Molecular pathogenesis of B cell lymphoma
2011-06-11 - English

Panel Discussion  

Panel discussion
2011-06-11 - English
to be announced!

Panel Discussion  

Panel discussion
2011-06-11 - English


E
Barbara Eichhorst  

Treatment of CLL in the elderly patients
2011-06-10 - English

Jeroen C.J. Eikenboom  

von Willebrand disease
2011-06-10 - English


F
A.A. Ferrando  

Molecular pathogenesis of T-ALL
2011-06-10 - English
to be announced!

Robin Foŕ  

Chair comments
2011-06-10 - English

Robin Foŕ  

Chair comments
2011-06-10 - English

Paul Frenette  

The stem cell niche
2011-06-10 - English


G
Guillermo Garcia Manero  

Treatment of MDS
2011-06-10 - English

John Gribben  

Updating treatment of CLL
2011-06-10 - English

Nicola Gökbuget  

ALL in the elderly
2011-06-10 - English
to be announced!


H
Gerald Haan  

Ageing of stem cells
2011-06-10 - English

Tilman Hackeng  

Tissue factor pathway inhibitor
2011-06-10 - English

Rupert Handgretinger  

Haploidentical donors
2011-06-10 - English

Henrik Hasle  

Diagnosis and management of childhood MDS
2011-06-10 - English

Jeanne Hendrickson  

Animal models to study red blood cell alloimmunization
2011-06-10 - English

Douglas Higgs  

Switching genes on and off during haematopoiesis: lessons from thalassaemia
2011-06-10 - English
to be announced!

Andreas Hochhaus  

Management of newly diagnosed patient
2011-06-10 - English

Tessa Holyoake  

Mechanisms of resistance in leukemic stem cells
2011-06-10 - English


I
Achille Iolascon  

New insights in congenital dyserythropoietic anemias
2011-06-10 - English


J
P.W.M. Johnson  

Today's treatment of Hodgkin lymphoma
2011-06-10 - English

Ulrich Jäger  

Chair comments
2011-06-10 - English
available!


K
Hagop Kantarjian  

Management of imatinib resistant patients
2011-06-10 - English

Aly Karsan  

Biology of MDS
2011-06-10 - English

Jean-Jacques Kiladjian  

Chair comments
2011-06-10 - English

Christoph Klein  

Stem cell defects in congenital disorders
2011-06-10 - English
to be announced!

Ralf Küppers  

Aspects of Hodgkin lymphoma pathogenesis
2011-06-10 - English


L
Jonathan Licht  

Molecular pathogenesis of AML
2011-06-10 - English

David Linch  

Today's therapy for patients with DLBCL
2011-06-10 - English

Bob Lowenberg  

Guiding treatment by molecular diagnostics
2011-06-10 - English

Bob Lowenberg  

Chair comments
2011-06-11 - English


M
Simón Méndez-Ferrer  

Bone marrow stem-cell niche: interplay and regulation
2011-06-11 - English

R. Mesa  

Myelofibrosis
2011-06-10 - English

Emili Montserrat  

Session Introduction
2011-06-10 - English

Philippe Moreau  

First line therapy for myeloma in 2011
2011-06-10 - English

Ghulam Mufti  

Stem cell transplantation
2011-06-10 - English
to be announced!


N
Adrian Newland  

Clinical management
2011-06-10 - English

France Noizat-Pirenne  

Relevance of RH variants in transfusion of sickle cell patients
2011-06-10 - English

Ulrike Nowak-Göttl  

Neonatal and childhood thrombosis
2011-06-10 - English


P
Ingrid Pabinger-Fasching  

Pregnancy and thrombosis
2011-06-10 - English

Laura Pasqualucci  

Relevant pathogenetic pathways in DLBCL
2011-06-10 - English
to be announced!

Antonio G. Piga  

How to assess the clinical relevance of iron overload
2011-06-10 - English

Francesco Pignatti  

Harmonisation of Drug Approval in Europe
2011-06-11 - English


R
Tannishtha Reya  

Molecular basis of blast crisis in CML
2011-06-12 - English

Katayoun Rezvani  

Vaccination of stem cell transplant recipients
2011-06-10 - English

I Roberts  

Chair comments
2011-06-10 - English

I Roberts  

Chair comments
2011-06-10 - English

Vanderson Rocha  

Cord blood donors
2011-06-10 - English

Jacob Rowe  

Clinical management of ALL
2011-06-10 - English

N.H. Russell  

Stem cell transplantation
2011-06-10 - English


S
Evan Sadler  

Chair comments
2011-06-10 - English

Giuseppe Saglio  

Clinical and academic perspective
2011-06-11 - English

Jesús San Miguel  

Clinical implications of cytogenetic aberrations in myeloma
2011-06-10 - English

Jesús San Miguel  

Chair comments
2011-06-10 - English

Rudolf Schoberberger  

Adherence - are you sure your patients are taking their medicines?
2011-06-11 - English

Sam Schulman  

New antithrombotic agents
2011-06-12 - English

Gérard Socié  

Late effects
2011-06-10 - English

Roberto Stasi  

Immune pathophysiology of ITP
2011-06-10 - English

Anna Sureda  

Role of auto and allografts in Hodgkin lymphoma
2011-06-10 - English


T
Enrico Tiacci  

BRAF MUTATIONS IN HAIRY CELL LEUKEMIA
2011-06-11 - English



W
Wyndham Wilson  

Treatment decisons based on molecular features
2011-06-10 - English



Use this index to quickly access speakers by name. A  B  C  D  E  F  G  H  I  J  K  L  M  N  O   P  Q   R  S  T  U   V  W  X   Y   Z